by
Gus Iversen, Editor in Chief | August 04, 2025
The American Medical Association has called on U.S. Health and Human Services Secretary Robert F. Kennedy to reverse reported plans to replace the entire U.S. Preventive Services Task Force, citing potential disruption to national clinical guidelines.
In a letter sent July 27, the Chicago-based organization said it is “deeply concerned” about reports that all current USPSTF members may be removed. The AMA warned that such an action could undermine the task force’s work in developing evidence-based recommendations for preventive services, including cancer screenings and mental health evaluations.
“USPSTF plays a critical, nonpartisan role in guiding physicians’ efforts to prevent disease and improve the health of patients by helping to ensure access to evidence-based clinical preventive services,” the AMA wrote. “We urge you to retain the previously appointed members of the USPSTF and commit to the long-standing process of regular meetings.”

Ad Statistics
Times Displayed: 357
Times Visited: 1 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
USPSTF members are appointed through a public nomination process and include nationally recognized experts in primary care, prevention, and evidence-based medicine. They serve as volunteers and are tasked with reviewing evidence to provide guidance on screenings, counseling, and preventive medications used in primary care.
The task force’s recommendations carry significant weight: under federal law, health insurers are required to cover USPSTF-endorsed services without cost-sharing. These include screenings for colorectal, breast, and lung cancer; evaluations for anxiety and depression in children; and cardiovascular disease prevention strategies.
The AMA noted that the task force’s work aligns with the Make America Healthy Again initiative and warned that any disruption could delay updates to clinical recommendations, potentially affecting patient care and public health outcomes.
No formal announcement from HHS has been issued. The agency has not responded publicly to the AMA’s letter.